The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers

Cancer Genetics
Yael LaitmanE Friedman

Abstract

Cancer risks in heterozygous mutation carriers of the ATM, BLM, and FANCC genes are controversial. To shed light on this issue, cancer rates were evaluated by cross referencing asymptomatic Israeli heterozygous mutation carriers in the ATM, BLM, and FANCC genes with cancer diagnoses registered at the Israeli National Cancer Registry (INCR). Comparison of observed to expected Standardized Incidence Rates (SIR) was performed. Overall, 474 individuals participated in the study: 378 females; 25 Arab and 31 Jewish ATM carriers, 152 BLM carriers, and 170 FANCC carriers (all Ashkenazim). Age range at genotyping was 19-53 years (mean + SD 30.6 + 5 years). In addition, 96 males were included; 5, 34, and 57 ATM, BLM, and FANCC mutation carriers, respectively. Over 5-16 years from genotyping (4721 person/years), 15 new cancers were diagnosed in mutation carriers: 5 breast, 4 cervical, 3 melanomas, and one each bone sarcoma, pancreatic, and colorectal cancer. No single cancer diagnosis was more prevalent then expected in all groups combined or per gene analyzed. Specifically breast cancer SIR was 0.02-0.77. We conclude that Israeli ATM, BLM, and FANCC heterozygous mutation carriers are not at an increased risk for developing cancer.

References

Dec 26, 1991·The New England Journal of Medicine·M SwiftC L Chase
Dec 1, 1996·Human Molecular Genetics·S GiladY Shiloh
Sep 21, 2002·Science·Stephen B GruberKenneth Offit
Sep 21, 2002·Science·Kathleen Heppner GossJoanna Groden
Jul 28, 2004·The American Journal of Pathology·Michiel S van der HeijdenScott E Kern
Jun 2, 2005·Journal of the National Cancer Institute·Deborah ThompsonDouglas F Easton
Aug 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maren WeischerBørge Grønne Nordestgaard
Sep 26, 2006·Oncogene·M Ahmed, N Rahman
Jun 20, 2008·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Jalal TarabeiaDorit Nitzan-Kaluski
Nov 1, 2008·Carcinogenesis·Shian-Ling DingChen-Yang Shen
Dec 1, 2009·Carcinogenesis·Bernd FrankHermann Brenner
Mar 30, 2010·Current Opinion in Genetics & Development·Antoinette HollestelleMieke Schutte
Aug 5, 2011·International Journal of Cancer. Journal International Du Cancer·Anna P SokolenkoEvgeny N Imyanitov
Mar 8, 2013·The Surgical Clinics of North America·David M Euhus, Linda Robinson
Oct 8, 2013·Gene·Andrzej AntczakMaria Małgorzata Sąsiadek
Apr 2, 2014·Molecular Genetics & Genomic Medicine·Joël Zlotogora

❮ Previous
Next ❯

Citations

Dec 22, 2017·Plastic and Reconstructive Surgery. Global Open·Jordan D FreyNolan S Karp
Jan 30, 2018·Nature Reviews. Cancer·Grzegorz Nalepa, D Wade Clapp
Oct 28, 2019·Pathology Oncology Research : POR·Pablo GargalloAdela Cañete
Apr 19, 2020·Breast Cancer Research and Treatment·Rinat Bernstein-MolhoYael Goldberg
Jun 27, 2020·Journal of Clinical Medicine·Mariona TerradasLaura Valle
Jul 4, 2017·Hereditary Cancer in Clinical Practice·Sergio CarreraGuillermo Lopez-Vivanco
Oct 17, 2019·Cancers·Wojciech KluźniakCezary Cybulski
Dec 16, 2020·Proceedings of the National Academy of Sciences of the United States of America·Angela BononiMichele Carbone
Feb 7, 2019·Deutsches Ärzteblatt International·Tilmann BochtlerCarsten Müller-Tidow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Related Papers

Breast Cancer Research and Treatment
Yael LaitmanE Friedman
International Journal of Cancer. Journal International Du Cancer
Fabio LeviCarlo La Vecchia
International Journal of Cancer. Journal International Du Cancer
Fabio LeviC La Vecchia
Journal of the National Cancer Institute
Deborah ThompsonDouglas F Easton
© 2022 Meta ULC. All rights reserved